These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31884111)
1. PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis. Jiang N; Li QL; Pan W; Li J; Zhang MF; Cao T; Su SG; Shen H Int J Biochem Cell Biol; 2020 Mar; 120():105681. PubMed ID: 31884111 [TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway. Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588 [TBL] [Abstract][Full Text] [Related]
3. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer. Lin M; Lei T; Zheng J; Chen S; Du L; Xie H Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078 [TBL] [Abstract][Full Text] [Related]
4. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway. Zhang Y; Zhang D; Lv J; Wang S; Zhang Q Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630 [TBL] [Abstract][Full Text] [Related]
5. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Lin Q; Chen H; Zhang M; Xiong H; Jiang Q Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003 [TBL] [Abstract][Full Text] [Related]
6. PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis. Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X Int J Med Sci; 2021; 18(15):3588-3598. PubMed ID: 34522186 [No Abstract] [Full Text] [Related]
7. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway. Wu ZH; Lin C; Liu CC; Jiang WW; Huang MZ; Liu X; Guo WJ Biochem Biophys Res Commun; 2018 Jul; 501(4):1068-1073. PubMed ID: 29777710 [TBL] [Abstract][Full Text] [Related]
8. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. Sun X; Hou L; Qiu C; Kong B Cell Mol Biol Lett; 2021 May; 26(1):20. PubMed ID: 34022794 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway. Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636 [TBL] [Abstract][Full Text] [Related]
10. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway. Zheng Y; Yang X; Wang C; Zhang S; Wang Z; Li M; Wang Y; Wang X; Yang X Sci Rep; 2020 Feb; 10(1):3576. PubMed ID: 32107418 [TBL] [Abstract][Full Text] [Related]
11. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells. Zhuo Z; Yu H Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207 [TBL] [Abstract][Full Text] [Related]
12. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
13. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926 [TBL] [Abstract][Full Text] [Related]
14. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137. Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425 [TBL] [Abstract][Full Text] [Related]
15. LncRNA IGF2-AS promotes endometriosis progression through targeting miR-370-3p/IGF2 axis and activating PI3K/AKT/mTOR signaling pathway. Jin X; Feng J; Cheng X J Assist Reprod Genet; 2022 Dec; 39(12):2699-2710. PubMed ID: 36508036 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
18. PELP1 oncogenic functions involve alternative splicing via PRMT6. Mann M; Zou Y; Chen Y; Brann D; Vadlamudi R Mol Oncol; 2014 Mar; 8(2):389-400. PubMed ID: 24447537 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Wu D; Huang HJ; He CN; Wang KY Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]